<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2D017FB7-303D-48E6-AAFF-06303F046804"><gtr:id>2D017FB7-303D-48E6-AAFF-06303F046804</gtr:id><gtr:name>Royal Marsden NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Radiotherapy and Imaging</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D017FB7-303D-48E6-AAFF-06303F046804"><gtr:id>2D017FB7-303D-48E6-AAFF-06303F046804</gtr:id><gtr:name>Royal Marsden NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6F16D9FF-8648-42CE-9776-F417865660EE"><gtr:id>6F16D9FF-8648-42CE-9776-F417865660EE</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Ind</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4C221037-AFC4-490B-BBEF-70831C993B18"><gtr:id>4C221037-AFC4-490B-BBEF-70831C993B18</gtr:id><gtr:firstName>Nandita</gtr:firstName><gtr:surname>deSouza</gtr:surname><gtr:orcidId>0000-0003-4232-476X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E271C608-B6D7-425E-A844-80D4D7982235"><gtr:id>E271C608-B6D7-425E-A844-80D4D7982235</gtr:id><gtr:firstName>Desmond</gtr:firstName><gtr:surname>Barton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5B28ACB9-0116-4049-83A9-5D516B03CCF6"><gtr:id>5B28ACB9-0116-4049-83A9-5D516B03CCF6</gtr:id><gtr:firstName>Ayoma</gtr:firstName><gtr:surname>Attygalle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/29244D64-5B7D-4997-A30C-7BDC5FF43C5F"><gtr:id>29244D64-5B7D-4997-A30C-7BDC5FF43C5F</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:otherNames>A.</gtr:otherNames><gtr:surname>Schmidt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802470"><gtr:id>D75C3ED7-D6C3-497B-953D-7A752563FF14</gtr:id><gtr:title>Diffusion-weighted MRI using an endovaginal coil for evaluating early cervical cancer</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802470</gtr:grantReference><gtr:abstractText>Magnetic resonance imaging is currently the gold standard for assessing the neck of the womb and surrounding tissues in cases of cervical or suspected cervical cancer. However, conventional techniques lack both resolution (pixel size 0.6 mm) and contrast when standard MRI pulse sequences are used. It is possible to increase the resolution of the images by placing a receiver probe close to the part under study to maximise signal and reduce noise from that region. We have previously developed an endovaginal receiver for use at 1.5T and shown significant improvement in resolution. However contrast between tumour and non-tumour tissue remains low and requires use of specialist sequences such as diffusion-weighted images which are inherently low on signal-to-noise ratio. Production of an endovaginal coil for use at a higher field strength (3.0T) would enable use of higher resolution diffusion-weighted imaging. We propose therefore to build an endovaginal device for use at 3.0T, optimize the diffusion-weighted imaging and compare the accuracy of conventional MRI techniques with and without the addition of diffusion-weighted imaging for detecting early stage cervical cancer by comparing with the tissue findings at surgery.</gtr:abstractText><gtr:technicalSummary>Endovaginal T2-W magnetic resonance imaging (MRI) techniques allow precise location of small cervical cancers, but accuracy of tumour detection is reduced post cone-biopsy because of cervical distortion, haematoma and granulation tissue. The signal-to-noise ratio improvement provided by an endovaginal coil enables acquisition of Diffusion-Weighted sequences (DW-MRI), which have the potential to differentiate small tumours from post-surgical change based on water diffusion within tissues. At 1.5T, our pilot data using an endovaginal coil indicates a trend to improve sensitivity for tumour detection when DW-MRI is used in conjunction with T2-W MRI. We wish to develop this technique for use at 3.0T which offers further gains in signal-to-noise ratio leading to better resolution and thus potentially improved accuracy for tumour detection. We propose to build an endovaginal coil for use at 3.0T (addressing issues such as increased susceptibility artefacts from coil components at higher field strength), integrate it with an external pelvic array coil, optimise the DW-MRI protocol and perform a blinded comparison of T2-W MRI with and without DW-MRI against a histological gold standard in patients with Stage Ia2 and Ib1 cervical cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>162552</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Marsden NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gynaecology Unit</gtr:department><gtr:description>academic partnership</gtr:description><gtr:id>57864B21-8EC2-4BB7-8F16-8AD3553F7B71</gtr:id><gtr:impact>Multidisciplinary
Surgery, Pathology, Radiology, Engineering, Physics

Altered patient management and allowed better planning of fertility sparing surgery for young women with cervical cancer</gtr:impact><gtr:outcomeId>RPRA9QQMeVr-1</gtr:outcomeId><gtr:partnerContribution>we have provided new imaging technology and methodology.
Surgical colleagues in our cancer centre and surrounding cancer networks (St. Georges Hospital, Epsom and St Heliers Hospitals, Kingston Hospital, Mayday Hospital Croydon have provided surgical expertise</gtr:partnerContribution><gtr:piContribution>linking imaging technology with surgical needs</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC London News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D5E047DC-9EBF-4F29-874E-1E70C10F7FB3</gtr:id><gtr:impact>BBC London News item

interest from patient groups</gtr:impact><gtr:outcomeId>YcRu1TJfZ2c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>189000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0802470</gtr:fundingRef><gtr:id>A493CCAE-C9DB-44D1-B37E-4B166D6C80E1</gtr:id><gtr:outcomeId>hQkLsXsK75F</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Design and testing of an endovaginal probe for MRI of the uterine cervix</gtr:description><gtr:grantRef>G0802470</gtr:grantRef><gtr:id>1A197645-9A4D-4590-8484-C7D33585B829</gtr:id><gtr:impact>Better diagnostics for patients with early cervical cancer</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>b41t6v852nW</gtr:outcomeId><gtr:patentId>EP1255119</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Endovaginal probe for MRI of the cervix</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Endovaginal MRI considered part of normal clinical practice at the Royal Marsden Hospital</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>81F1F4A4-85B0-4073-BF38-5A3CD395FB30</gtr:id><gtr:impact>Impacts on the delivery of fertility sparing surgery to young women with cervical cancer</gtr:impact><gtr:outcomeId>tpKmtSPfbPT</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Endovaginal coil for imaging the cervix at 3T</gtr:description><gtr:id>7E6D7E06-C2B3-4EA3-BC4D-FDEAA0D1F568</gtr:id><gtr:impact>Improved cervical cancer diagnosis and selection of patients for fertility sparing surgery</gtr:impact><gtr:outcomeId>TVmaJfzmnc4</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Endovaginal receiver coil</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:ukcrnIsctnId>04/Q0801/21</gtr:ukcrnIsctnId><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New method of imaging the cervix to visualize small tumours</gtr:description><gtr:id>7C7B1E04-2C4F-4F5E-BB52-88CA5B298009</gtr:id><gtr:impact>Better surgical decision-making for patients with early cervical cancer wishing to preseve fertility</gtr:impact><gtr:outcomeId>oNtAM5vTeZP</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Endovaginal probe for MRI of the cervix for early cervical cancer</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DF6582FB-4E5E-421E-A384-BBB76220963A</gtr:id><gtr:title>Coil design for imaging the uterine cervix at 3T. Control of r.f. eddy currents</gtr:title><gtr:parentPublicationTitle>Proceedings ISMRM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a75d950cc72b22501c168e2521f445d"><gtr:id>1a75d950cc72b22501c168e2521f445d</gtr:id><gtr:otherNames>Gilderdale DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>hCAgZFBFnMN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7349AADC-87F1-4435-8BEF-C6AC82A96353</gtr:id><gtr:title>Separation of type and grade in cervical tumours using non-mono-exponential models of diffusion-weighted MRI.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68e1a7d162daf951d7000ce7c1d14451"><gtr:id>68e1a7d162daf951d7000ce7c1d14451</gtr:id><gtr:otherNames>Winfield JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>576aa970e52351.41441585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34171945-D455-4169-B385-6B0B6D1A1E9A</gtr:id><gtr:title>Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14feb638d62f8a29dda2d0fb9c404217"><gtr:id>14feb638d62f8a29dda2d0fb9c404217</gtr:id><gtr:otherNames>Payne GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>pm_16094_14_19875159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CA315FF-E8E3-4832-BC58-414A3E5DEC92</gtr:id><gtr:title>Endovaginal magnetic resonance imaging of Stage 1A/1B1 cervical cancer with a T2- and diffusion-weighted magnetic resonance technique: Effect of lesion size and previous cone biopsy on tumor detectability</gtr:title><gtr:parentPublicationTitle>Proceedings ISMRM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ccd01b66a7a63eee0923b73dc37f0a0"><gtr:id>3ccd01b66a7a63eee0923b73dc37f0a0</gtr:id><gtr:otherNames>Charles-Edwards E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>K6Zpi8Np4Z1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13958ADE-593B-4EF0-A487-AC65852156DA</gtr:id><gtr:title>Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>56d700e7a0cbc1.24524163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B69D16FB-EFC2-45F9-9848-E001638F42EA</gtr:id><gtr:title>Preoperative imaging in patients undergoing trachelectomy for cervical cancer: validation of a combined T2- and diffusion-weighted endovaginal MRI technique at 3.0 T.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>545255f0774349.56651655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7D592DE-7E44-4ECA-89E5-ADC2F16E066F</gtr:id><gtr:title>Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in Stage 1 cervical cancer.</gtr:title><gtr:parentPublicationTitle>Proceedings ISMRM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6dd907c53f087c7e41963285d8c19a"><gtr:id>4d6dd907c53f087c7e41963285d8c19a</gtr:id><gtr:otherNames>Schmidt M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>Y9DY2aVYedL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D71608D-3DAA-431B-A4E5-BA2FAE997DEE</gtr:id><gtr:title>Clinical Feasibility of Distortion Corrected Diffusion-Weighted (DW) Images of Human Cervix</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfc460ebf71dfb0a119c204ccc254c99"><gtr:id>dfc460ebf71dfb0a119c204ccc254c99</gtr:id><gtr:otherNames>Jafar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546237dfcf0627.27908475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCEAF772-082C-4F61-8F8D-CD36CD57E1C3</gtr:id><gtr:title>Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e912836daef49ef82b32c4def74c2a9"><gtr:id>5e912836daef49ef82b32c4def74c2a9</gtr:id><gtr:otherNames>Charles-Edwards EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn><gtr:outcomeId>pm_16094_14_18936313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD33810-E974-4751-973A-8C39993F9BC3</gtr:id><gtr:title>Endovaginal magnetic resonance imaging of stage 1A/1B cervical cancer with A T2- and diffusion-weighted magnetic resonance technique: effect of lesion size and previous cone biopsy on tumor detectability.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ccd01b66a7a63eee0923b73dc37f0a0"><gtr:id>3ccd01b66a7a63eee0923b73dc37f0a0</gtr:id><gtr:otherNames>Charles-Edwards E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>54539a7c268ae9.65550680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B633E12E-17E0-4893-978E-1895349B54D3</gtr:id><gtr:title>Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14feb638d62f8a29dda2d0fb9c404217"><gtr:id>14feb638d62f8a29dda2d0fb9c404217</gtr:id><gtr:otherNames>Payne GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>56d700e867d644.85822002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2CF32AA-C29F-40FF-8B43-C1213D21CB85</gtr:id><gtr:title>Characterising heterogeneity of Stage 1 cervical cancers using histogram analysis from diffusion weighted images</gtr:title><gtr:parentPublicationTitle>Proceedings of ISMRM 2011</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>PCMbn5Rtyjh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>450CC6DC-561A-4C35-8207-4B15ED505BE2</gtr:id><gtr:title>Imaging cervical cancer: recent advances and future directions.</gtr:title><gtr:parentPublicationTitle>Current opinion in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1040-8746</gtr:issn><gtr:outcomeId>5458b20983d343.44793891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F30B6436-0D6C-460C-BE4D-FCE471F97797</gtr:id><gtr:title>Distortion correction of echo-planar diffusion-weighted images of uterine cervix.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400e14fcc663e3a6814fb1d70dce02bf"><gtr:id>400e14fcc663e3a6814fb1d70dce02bf</gtr:id><gtr:otherNames>deSouza NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn><gtr:outcomeId>56d700e64bc789.08381213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56C1789F-713A-4399-A21D-C3CBCD720220</gtr:id><gtr:title>Characterisation of mobile lipid resonances in tissue biopsies from patients with cervical cancer and correlation with cytoplasmic lipid droplets.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1c90abccb49b0c538f63e13aba2c21a"><gtr:id>e1c90abccb49b0c538f63e13aba2c21a</gtr:id><gtr:otherNames>Zietkowski D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>545397ba54a984.95844353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>549FEE5D-40C7-4202-9EF8-95216A5713AC</gtr:id><gtr:title>Influencing surgical management in patients with carcinoma of the cervix using a T2- and ZOOM-diffusion-weighted endovaginal MRI technique.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>doi_55f985985038e4fa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>461FEFD9-D25D-414F-B340-738DA57607B3</gtr:id><gtr:title>Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.</gtr:title><gtr:parentPublicationTitle>AJR. American journal of roentgenology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8710122796b1c39a0cfa01badedab5b8"><gtr:id>8710122796b1c39a0cfa01badedab5b8</gtr:id><gtr:otherNames>Downey K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0361-803X</gtr:issn><gtr:outcomeId>DPRhUwfM93Z</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802470</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>